Diabetes drug semaglutide may lower dementia risk, huge study suggests
NCT ID NCT05768945
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study looked at medical records from over 740,000 older adults with diabetes to see if those taking semaglutide had a lower risk of developing dementia compared to those on other diabetes drugs (DPP4 inhibitors). The goal was to find out if semaglutide might help protect the brain. Because this is an analysis of existing data, it can suggest a link but cannot prove that semaglutide directly prevents dementia.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
semaglutide
What this could lead to
If semaglutide is linked to lower dementia risk, this could point toward repurposing it to prevent Alzheimer's in people with diabetes.
What could go wrong
This is an observational analysis, not a controlled trial. It can show links but not prove cause and effect. Results may not apply to people without diabetes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States